Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours.
Zucali PA, Simonelli M, De Vincenzo F, Lorenzi E, Perrino M, Bertossi M, Finotto R, Naimo S, Balzarini L, Bonifacio C, Timofeeva I, Rossoni G, Mazzola G, Lambiase A, Bordignon C, Santoro A.
Zucali PA, et al.
Br J Cancer. 2013 Jan 15;108(1):58-63. doi: 10.1038/bjc.2012.506. Epub 2012 Nov 20.
Br J Cancer. 2013.
PMID: 23169299
Free PMC article.
Clinical Trial.